General information about company
Scrip code*		540204
NSE Symbol*		NOTLISTED
MSEI Symbol*		NOTLISTED
ISIN*		INE666Q01016
Name of company		EIKO LIFESCIENCES LIMITED
Type of company		Main Board
Class of security		Equity
Date of start of financial year		01-04-2026
Date of end of financial year		31-03-2027
Date of board meeting when results were approved		12-08-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange		07-08-2026
Description of presentation currency		INR
Level of rounding		Lakhs
Reporting Type		Quarterly
Reporting Quarter		First quarter
Nature of report standalone or consolidated		Consolidated
Whether results are audited or unaudited for the quarter ended		Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting		Multi segment
Description of single segment
Start date and time of board meeting		12-08-2026 13:00
End date and time of board meeting		12-08-2026 13:40
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification		Not applicable

Financial Results – Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2026	01-04-2026
Date of end of reporting period		30-06-2026	30-06-2026
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	1674.88	1674.88
	Other income	41.08	41.08
	Total income	1715.96	1715.96
2	Expenses
(a)	Cost of materials consumed	1393.79	1393.79
(b)	Purchases of stock-in-trade	0	0
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	-40.96	-40.96
(d)	Employee benefit expense	19.91	19.91
(e)	Finance costs	13.01	13.01
(f)	Depreciation, depletion and amortisation expense	25.36	25.36
(g)	Other Expenses
1	Other Expenses	108.41	108.41
	Total other expenses	108.41	108.41
	Total expenses	1519.52	1519.52
3	Total profit before exceptional items and tax	196.44	196.44
4	Exceptional items	0	0
5	Total profit before tax	196.44	196.44
6	Tax expense
7	Current tax	43.75	43.75
8	Deferred tax	5.34	5.34
9	Total tax expenses	49.09	49.09
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	147.35	147.35
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	3.48	3.48
16	Total profit (loss) for period	150.83	150.83
17	Other comprehensive income net of taxes	0	0
18	Total Comprehensive Income for the period	150.83	150.83
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	130.79	130.79
	Total profit or loss, attributable to non-controlling interests	20.04	20.04
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	130.79	130.79
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	20.04	20.04
21	Details of equity share capital
	Paid-up equity share capital	1434.59	1434.59
	Face value of equity share capital	10	10
22	Reserves excluding revaluation reserve
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	0.91	0.91
	Diluted earnings (loss) per share from continuing operations	0.76	0.76
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
iii	Earnings per equity share (for continuing and discontinued operations)
	Basic earnings (loss) per share from continuing and discontinued operations	0.91	0.91
	Diluted earnings (loss) per share from continuing and discontinued operations	0.76	0.76
24	Debt equity ratio			Textual Information( 1)
25	Debt service coverage ratio			Textual Information( 2)
26	Interest service coverage ratio			Textual Information( 3)
27	Disclosure of notes on financial results	Textual Information(4)

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-04-2026	01-04-2026
Date of end of reporting period		30-06-2026	30-06-2026
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Specialty & Fine Chemicals	1525.32	1525.32
2	Logistics	149.56	149.56
	Total Segment Revenue	1674.88	1674.88
	Less: Inter segment revenue	0	0
	Revenue from operations	1674.88	1674.88
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Specialty & Fine Chemicals	98.86	98.86
2	Logistics	28.67	28.67
	Total Profit before tax	127.53	127.53
	i. Finance cost	13.01	13.01
	ii. Other Unallocable Expenditure net off Unallocable income	-85.41	-85.41
	Profit before tax	199.93	199.93
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Specialty & Fine Chemicals	4056.11	4056.11
2	Logistics	1594.98	1594.98
	Total Segment Asset	5651.09	5651.09
	Un-allocable Assets	2744.66	2744.66
	Net Segment Asset	8395.75	8395.75
4	Segment Liabilities
	Segment Liabilities
1	Specialty & Fine Chemicals	1079.6	1079.6
2	Logistics	182.83	182.83
	Total Segment Liabilities	1262.43	1262.43
	Un-allocable Liabilities	0	0
	Net Segment Liabilities	1262.43	1262.43
	Disclosure of notes on segments

Other Comprehensive Income
Date of start of reporting period		01-04-2026	01-04-2026
Date of end of reporting period		30-06-2026	30-06-2026
Whether results are audited or unaudited		Unaudited	Unaudited
Nature of report standalone or consolidated		Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
	Total Amount of items that will not be reclassified to profit and loss
2	Income tax relating to items that will not be reclassified to profit or loss	0.00	0.00
3	Amount of items that will be reclassified to profit and loss
	Total Amount of items that will be reclassified to profit and loss
4	Income tax relating to items that will be reclassified to profit or loss	0.00	0.00
5	Total Other comprehensive income	0.00	0.00

General information about company

Financial Results – Ind-AS

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Other Comprehensive Income